180 related articles for article (PubMed ID: 6246841)
1. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
[TBL] [Abstract][Full Text] [Related]
2. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
[TBL] [Abstract][Full Text] [Related]
4. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
[TBL] [Abstract][Full Text] [Related]
5. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
Hirschman GH; DeLuca HF; Chan JC
Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypophosphataemic vitamin D-resistant rickets.
Kristiansen JH; Pedersen VF
Arch Dis Child; 1981 Jan; 56(1):76-7. PubMed ID: 6258488
[No Abstract] [Full Text] [Related]
8. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatemic vitamin D resistant rickets treatment with one alpha hydroxy vitamin D3.
Tragler A; Pai BU
Indian Pediatr; 1989 Apr; 26(4):386-8. PubMed ID: 2557284
[No Abstract] [Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
11. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphataemic vitamin-D resistant rickets may need phosphate supplements.
Price HV; Woodhead JS
Br Med J (Clin Res Ed); 1982 May; 284(6327):1442-3. PubMed ID: 6282378
[No Abstract] [Full Text] [Related]
15. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
[TBL] [Abstract][Full Text] [Related]
16. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
Scriver CR; Reade T; Halal F; Costa T; Cole DE
Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
[No Abstract] [Full Text] [Related]
18. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
Delvin EE; Glorieux FH
Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
[TBL] [Abstract][Full Text] [Related]
19. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
Brickman AS; Coburn JW; Kurokawa K; Bethune JE; Harrison HE; Norman AW
N Engl J Med; 1973 Sep; 289(10):495-8. PubMed ID: 4353218
[No Abstract] [Full Text] [Related]
20. [Vitamin D-resistant rickets type II: apropos of 2 cases].
Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
